24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publication dates

Carcinoma Industry, September 2014 Market Reports from Top Publishers

You might be interested in: cancer, diagnostic, microbiology, more »


 
1-10 of 64 reports for Carcinoma

Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2014

Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • September 2014
  • by Global Markets Direct

... Scope- the report provides a snapshot of the global therapeutic landscape of recurrent head and neck cancer squamous cell carcinoma- the report reviews key pipeline products under drug profile section which ...

Global Non-small Cell Lung Cancer Market 2014-2018

Global Non-small Cell Lung Cancer Market 2014-2018

  • $ 2 500
  • Industry report
  • September 2014
  • by Infiniti Research Limited

... Undifferentiated) carcinoma. Some of the common symptoms associated with non-small cell lung cancer are chest pain, a cough that does not go away, coughing up blood, fatigue, loss of appetite, losing weight without ...

Colon Carcinoma - Pipeline Review, H2 2014

Colon Carcinoma - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • August 2014
  • by Global Markets Direct

... A snapshot of the global therapeutic landscape of colon carcinoma- the report reviews key pipeline products under drug profile section which includes, product description, moa and r&d brief, licensing ...

EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023

EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • August 2014
  • by Global Data

... By identifying the sex and age groups that present the best opportunities for rcc therapeutics in each of the markets covered. Epicast report: renal cell carcinoma - epidemiology forecast to 2023 1 table ...

Sunshine Biopharma, Inc. (Symbol:SBFM) SWOT Analysis, Strategy, Revenues and Profits

Sunshine Biopharma, Inc. (Symbol:SBFM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

... Targeted for various forms of cancer such as breast cancer (mcf-7/mdr), small-cell lung cancer (h69ar), uterine carcinoma (mes-sa/dx5) and pancreatic cancer (panc-1). The company also offers difluoro ...

 Adrenocortical Carcinoma (Adrenal Cortex Cancer)-Pipeline Insights, 2014

Adrenocortical Carcinoma (Adrenal Cortex Cancer)-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... Comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under adrenocortical carcinoma (adrenal ...

 Basal Cell Carcinoma-Pipeline Insights, 2014

Basal Cell Carcinoma-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... This indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under basal cell carcinoma. This report provides information on the therapeutic development ...

 Basal Cell Carcinoma (Basal Cell Epithelioma)-Pipeline Insights, 2014

Basal Cell Carcinoma (Basal Cell Epithelioma)-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... Comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under basal cell carcinoma (basal cell ...

 Colon Carcinoma-Pipeline Insights, 2014

Colon Carcinoma-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... This indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under colon carcinoma. This report provides information on the therapeutic development based ...

 Gastroesophageal (GE) Junction Carcinomas-Pipeline Insights, 2014

Gastroesophageal (GE) Junction Carcinomas-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... Insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under gastroesophageal (ge) junction carcinomas ...

About 2 500 reports for Carcinoma

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Pakistan and United Arab Emirates

  • Demographic Review, Clinical and Histological Presentation of Pa...
  • January 2012
    3 pages
  • Cancer  

    Carcinoma  

  • Pakistan  

    United Arab Emi...  

View report >

Us - Economic Analysis

October 2012

8 Companies for Carcinoma

Read our Company Profiles

Novartis Inc.

Switzerland

Eli Lilly and Co.

United States

Lilly and Co.

United States

AstraZeneca PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.